OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
40
Results
Show all
Save search
Copy query
Show results for
Unknown
(40)
Publication Date
Release Date
2021
(9)
2020
(5)
2022
(4)
2019
(4)
2018
(4)
2024
(3)
2023
(3)
2025
(2)
2015
(1)
2012
(1)
2011
(1)
2010
(1)
2009
(1)
2008
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Minor sequence modifications in temporin B cause drastic changes in antibacterial potency and selectivity by fundamentally altering membrane activity.
Not available
S-EPMC6362004
|
biostudies-literature
Cite
Detection of Genomic Structural Variations Associated with Drug Sensitivity and Resistance in Acute Leukemia.
Not available
S-EPMC10814465
|
biostudies-literature
Cite
Development of Novel Membrane Disrupting Lipoguanidine Compounds Sensitizing Gram-Negative Bacteria to Antibiotics.
Not available
S-EPMC10860194
|
biostudies-literature
Cite
A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy.
Not available
S-EPMC7699649
|
biostudies-literature
Cite
Maternal iodine status in a multi-ethnic UK birth cohort: associations with autism spectrum disorder.
Not available
S-EPMC7718710
|
biostudies-literature
Cite
Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases.
Not available
S-EPMC10636885
|
biostudies-literature
Cite
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.
Not available
S-EPMC7309367
|
biostudies-literature
Cite
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease.
Not available
S-EPMC6367005
|
biostudies-literature
Cite
An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations.
Not available
S-EPMC6858549
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets